Suppr超能文献

低血清胆固醇水平预示外周 T 细胞淋巴瘤,未特指患者预后不良,并改善预后指数评分。

Low serum cholesterol levels predict inferior prognosis and improve prognostic index scoring for peripheral T-cell lymphoma, unspecified.

机构信息

Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China; Key Laboratory of Hematology of Nanjing Medical University, Nanjing 210029, China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing 210029, China.

Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China; Key Laboratory of Hematology of Nanjing Medical University, Nanjing 210029, China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing 210029, China.

出版信息

Leuk Res. 2021 Apr;103:106534. doi: 10.1016/j.leukres.2021.106534. Epub 2021 Feb 15.

Abstract

Peripheral T-cell lymphomas, unspecified (PTCL-U) is a heterogeneous group of non-Hodgkin lymphomas, arising from the transformation of mature, post-thymic T-cells. Prognostic index for PTCL-U (PIT) is based on Europeans and may not be applicable for Chinese PTCL-U patients. Besides, low circulating cholesterol concentration is associated with elevated cancer incidence and mortality. The purpose of our study was to assess the prognostic value of serum lipid levels in PTCL-U and improve PIT. We screened the prognostic factors associated with progression-free survival (PFS) and overall survival (OS) by multivariate Cox regression analysis in ninety-one enrolled patients. The results showed that low-level high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) were associated with unfavorable OS. Furthermore, we developed a new risk model, PITC, based on low-level HDL-C, LDL-C and PIT. In Chinese PTCL-U, PITC was superior to PIT in PFS and OS. In conclusion, serum cholesterol levels may be good candidates for predicting prognosis in PTCL-U.

摘要

外周 T 细胞淋巴瘤,未特指 (PTCL-U) 是一组异质性非霍奇金淋巴瘤,起源于成熟的、胸腺后 T 细胞的转化。PTCL-U 的预后指数 (PIT) 基于欧洲人群,可能不适用于中国的 PTCL-U 患者。此外,循环胆固醇浓度低与癌症发病率和死亡率升高有关。我们的研究目的是评估血清脂质水平在 PTCL-U 中的预后价值,并改进 PIT。我们通过对 91 名入组患者的多变量 Cox 回归分析筛选出与无进展生存期 (PFS) 和总生存期 (OS) 相关的预后因素。结果表明,低水平高密度脂蛋白胆固醇 (HDL-C) 和低密度脂蛋白胆固醇 (LDL-C) 与 OS 不良相关。此外,我们基于低水平的 HDL-C、LDL-C 和 PIT 建立了一个新的风险模型,PITC。在中国的 PTCL-U 中,PITC 在 PFS 和 OS 方面优于 PIT。总之,血清胆固醇水平可能是预测 PTCL-U 预后的良好候选指标。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验